Unilateral primary aldosteronism considerations about the diagnostic criteria, adrenalectomy, and short and long time biochemical and clinical evaluation.
作者信息
Armanini Decio, Boscaro Marco, Sabbadin Chiara, Bordin Luciana
机构信息
Department of Medicine-Endocrinology, Università degli Studi di Padova, Padova, Italy.
Department of Molecular Medicine-Biological Chemistry, Università degli Studi di Padova, Padova, Italy.
出版信息
J Clin Hypertens (Greenwich). 2022 Feb;24(2):116-118. doi: 10.1111/jch.14394. Epub 2021 Nov 30.
Abstract
摘要
相似文献
1
Unilateral primary aldosteronism considerations about the diagnostic criteria, adrenalectomy, and short and long time biochemical and clinical evaluation.单侧原发性醛固酮增多症：关于诊断标准、肾上腺切除术以及短期和长期生化及临床评估的思考
J Clin Hypertens (Greenwich). 2022 Feb;24(2):116-118. doi: 10.1111/jch.14394. Epub 2021 Nov 30.
2
Nomogram-Based Preoperative Score for Predicting Clinical Outcome in Unilateral Primary Aldosteronism.基于列线图的单侧原发性醛固酮增多症术前评分预测临床转归。
J Clin Endocrinol Metab. 2020 Dec 1;105(12). doi: 10.1210/clinem/dgaa634.
3
KCNJ5 Somatic Mutation Is a Predictor of Hypertension Remission After Adrenalectomy for Unilateral Primary Aldosteronism.KCNJ5 体细胞突变是单侧原发性醛固酮增多症肾上腺切除术治疗后高血压缓解的预测因子。
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4695-4702. doi: 10.1210/jc.2019-00531.
4
Letter to the Editor: Validation of the aldosteronoma resolution score as a predictive resolution score of hypertension after unilateral adrenalectomy for primary aldosteronism in a North-African population.致编辑的信：醛固酮瘤消退评分作为北非人群原发性醛固酮增多症单侧肾上腺切除术后高血压预测消退评分的验证
World J Surg. 2024 Feb;48(2):497-498. doi: 10.1002/wjs.12030. Epub 2023 Dec 8.
5
Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?原发性高血压：原发性醛固酮增多症单侧肾上腺切除术后持续性高血压的首要原因？
Surgery. 1998 Dec;124(6):1128-33. doi: 10.1067/msy.1998.93108.
6
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.单侧原发性醛固酮增多症肾上腺切除术的结局：国际共识的结局指标和国际队列缓解率分析。
Lancet Diabetes Endocrinol. 2017 Sep;5(9):689-699. doi: 10.1016/S2213-8587(17)30135-3. Epub 2017 May 30.
7
[Recent progress of diagnosis and treatment of primary aldosteronism].[原发性醛固酮增多症的诊断与治疗新进展]
Nihon Rinsho. 2011 Nov;69(11):2071-6.
8
A comprehensive review of the clinical aspects of primary aldosteronism.原发性醛固酮增多症的临床综述。
Nat Rev Endocrinol. 2011 May 24;7(8):485-95. doi: 10.1038/nrendo.2011.76.
9
Treatment of Unilateral PA by Adrenalectomy: Potential Reasons for Incomplete Biochemical Cure.肾上腺切除术治疗单侧原发性醛固酮增多症：生化治愈不完全的潜在原因
Exp Clin Endocrinol Diabetes. 2019 Feb;127(2-03):100-108. doi: 10.1055/a-0662-6081. Epub 2018 Aug 21.
10
Refining the Definitions of Biochemical and Clinical Cure for Primary Aldosteronism Using the Primary Aldosteronism Surgical Outcome (PASO) Classification System.使用原发性醛固酮增多症手术结果（PASO）分类系统完善原发性醛固酮增多症生化治愈和临床治愈的定义
World J Surg. 2018 Feb;42(2):453-463. doi: 10.1007/s00268-017-4311-1.
本文引用的文献
1
Prognosis of adrenalectomy guided by computed tomography versus adrenal vein sampling in patients with primary aldosteronism: A systematic review and meta-analysis.计算机断层扫描引导下肾上腺切除术与肾上腺静脉采样在原发性醛固酮增多症患者中的预后比较：系统评价和荟萃分析。
J Clin Hypertens (Greenwich). 2022 Feb;24(2):106-115. doi: 10.1111/jch.14395. Epub 2022 Jan 22.
2
Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis.肾上腺成像在原发性醛固酮增多症亚型诊断中的诊断准确性：系统评价和荟萃分析。
BMJ Open. 2020 Dec 31;10(12):e038489. doi: 10.1136/bmjopen-2020-038489.
3
Enigma of the Origin of Primary Aldosteronism.原发性醛固酮增多症的起源之谜。
Hypertension. 2019 Oct;74(4):745-746. doi: 10.1161/HYPERTENSIONAHA.119.13302. Epub 2019 Sep 3.
4
Assessing outcomes after adrenalectomy for unilateral primary aldosteronism.评估单侧原发性醛固酮增多症肾上腺切除术后的结果。
Surgery. 2019 Dec;166(6):1199-1200. doi: 10.1016/j.surg.2019.06.027. Epub 2019 Aug 2.
5
Clinical outcomes after surgery for primary aldosteronism: Evaluation of the PASO-investigators' consensus criteria within a worldwide cohort of patients.原发性醛固酮增多症患者手术后的临床结局：在全球范围内的患者队列中评估 PASO 研究者共识标准。
Surgery. 2019 Jul;166(1):61-68. doi: 10.1016/j.surg.2019.01.031. Epub 2019 May 1.
6
Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.经医学治疗的原发性醛固酮增多症的心脏代谢结局和死亡率：一项回顾性队列研究。
Lancet Diabetes Endocrinol. 2018 Jan;6(1):51-59. doi: 10.1016/S2213-8587(17)30367-4. Epub 2017 Nov 9.
7
Contralateral suppression of aldosterone at adrenal venous sampling predicts hyperkalemia following adrenalectomy for primary aldosteronism.肾上腺静脉采血时醛固酮的对侧抑制可预测原发性醛固酮增多症肾上腺切除术后的高钾血症。
Surgery. 2018 Jan;163(1):183-190. doi: 10.1016/j.surg.2017.07.034. Epub 2017 Nov 9.
8
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.单侧原发性醛固酮增多症肾上腺切除术的结局：国际共识的结局指标和国际队列缓解率分析。
Lancet Diabetes Endocrinol. 2017 Sep;5(9):689-699. doi: 10.1016/S2213-8587(17)30135-3. Epub 2017 May 30.
9
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.原发性醛固酮增多症的管理：病例检出、诊断和治疗：内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2016 May;101(5):1889-916. doi: 10.1210/jc.2015-4061. Epub 2016 Mar 2.
10
Aldosterone receptor blockers spironolactone and canrenone: two multivalent drugs.醛固酮受体阻滞剂螺内酯和坎利酮：两种多价药物。
Expert Opin Pharmacother. 2014 May;15(7):909-12. doi: 10.1517/14656566.2014.896901. Epub 2014 Mar 11.
Zotero 插件